IM Therapeutics Spins Out of University of Colorado to Focus on Type 1 Diabetes Post author:Sam Post published:November 9, 2017 Post category:BioPharma ImmunoMolecular Therapeputics officially launched yesterday. Source: BioSpace You Might Also Like Alzheon Launches IPO to Fund Alzheimer's Drug March 18, 2018 Phenomenex Announces Direct Sales And Support In Switzerland September 5, 2017 Mallinckrodt Reports Second Quarter 2017 Results August 3, 2017
